trending Market Intelligence /marketintelligence/en/news-insights/trending/ypgsvnybwn47ungehv814q2 content esgSubNav
In This List

Illumina appoints chief medical officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Illumina appoints chief medical officer

Genetic testing services provider Illumina Inc. appointed Phil Febbo as chief medical officer, effective March 26.

Febbo most recently served as chief medical officer of Genomic Health, Inc., a provider of genomic information to personalize cancer treatment.